HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

被引:133
作者
Riteau, B
Menier, C
Khalil-Daher, I
Martinozzi, S
Pla, M
Dausset, J
Carosella, ED
Rouas-Freiss, N
机构
[1] Hop St Louis, DSV, DRM, CEA,Serv Rech Hematoimmunol,IUH, F-75475 Paris 10, France
[2] Hop St Louis, IUH, INSERM U462, F-75475 Paris, France
[3] Fdn Jean Dausset, F-75010 Paris, France
关键词
cytotoxicity; human; MHC; NK cells; tolerance;
D O I
10.1093/intimm/13.2.193
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is now acknowledged that the pattern of HLA-G expression is not restricted to extravillous cytotrophoblast cells, as several studies described HLA-G in HLA class If cells, such as thymic epithelial cells, cytokine-activated monocytes and some tumors, In these situations, HLA-G may provide an additional inhibitory signal to escape from NK cell-mediated cytotoxicity, Accordingly, the aim of this study was to define the behavior of HLA-G once it is cc-expressed into an HLA-A, -B, -C and -E+ cell line, For this purpose, HLA-G1 cDNA was transfected into an HLA class I+ melanoma cell line which was used as a target towards freshly isolated peripheral blood NK cells, Cytotoxic experiments using either anti-HLA-G1 or anti-HLA-G1 inhibitory receptor mAb show that HLA-G1 boosts the HLA class I-mediated inhibition of polyclonal Nh cells through interaction with ILT-2, which appears as the major HLA-G1 inhibitory receptor involved. Nevertheless, HLA-G1 is also able to inhibit the cytolytic activity of an ILT-2- NK clone which otherwise expresses another HLA-G1 inhibitory receptor belonging to the KIR103 gene family, In order to more precisely define the relative role exerted by HLA-G1 versus -E on polyclonal NK cells, antibody-blocking assays were carried out using either anti-HLA class I or anti-CD94/NKG2A, Results demonstrate that in the absence of HLA-G1, the naturally expressed HLA class I-mediated NK inhibition is predominantly exerted by HLA-E through binding with CD94/NKG2A, In contrast, once HLA-G1 is expressed, it becomes the major NK inhibitory ligand.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 46 条
[11]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[12]   A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules [J].
Cosman, D ;
Fanger, N ;
Borges, L ;
Kubin, M ;
Chin, W ;
Peterson, L ;
Hsu, ML .
IMMUNITY, 1997, 7 (02) :273-282
[13]   Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts [J].
Crisa, L ;
McMaster, MT ;
Ishii, JK ;
Fisher, SJ ;
Salomon, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :289-298
[14]   Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules [J].
Jun, Y ;
Kim, E ;
Jin, MR ;
Sung, HC ;
Han, H ;
Geraghty, DE ;
Ahn, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :805-811
[15]   Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself [J].
Khalil-Daher, I ;
Riteau, B ;
Menier, C ;
Sedlik, C ;
Paul, P ;
Dausset, J ;
Carosella, ED ;
Rouas-Freiss, N .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1999, 43 (02) :175-182
[16]   A CLASS-I ANTIGEN, HLA-G, EXPRESSED IN HUMAN TROPHOBLASTS [J].
KOVATS, S ;
MAIN, EK ;
LIBRACH, C ;
STUBBLEBINE, M ;
FISHER, SJ ;
DEMARS, R .
SCIENCE, 1990, 248 (4952) :220-223
[17]   CYTOMEGALOVIRUS ISOLATIONS ASSOCIATED WITH PREGNANCY WASTAGE [J].
KRIEL, RL ;
GATES, GA ;
WULFF, H ;
POWELL, N ;
POLAND, JD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1970, 106 (06) :885-+
[18]   NK cell receptors [J].
Lanier, LL .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :359-393
[19]   HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes [J].
Le Gal, FA ;
Riteau, B ;
Sedlik, C ;
Khalil-Daher, I ;
Menier, C ;
Dausset, J ;
Guillet, JG ;
Carosella, ED ;
Rouas-Freiss, N .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (08) :1351-1356
[20]  
Lee N, 1998, J IMMUNOL, V160, P4951